SkyWest, Inc. (NASDAQ: SKYW) ("SkyWest") today reported financial and operating results for Q4 2024, including net income of $97 million, or $2.34 per diluted share ...

Avid Bioservices, Inc. (NASDAQ: CDMO) ("Avid" or the "Company"), a dedicated biologics contract development and manufacturing organization ("CDMO") working ...

Q4 2024. Management View. Lane Riggs, Chairman and CEO, highlighted that Valero processed record volumes of heavy sour ...

Tony Thene, President and CEO, highlighted that the company delivered a record second quarter with $119 million in operating income, a 70% increase year-over-year. He emphasized that the company’s SAO ...

Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is ...